LifeStance Health (LFST) Return on Equity (2021 - 2025)
LifeStance Health (LFST) has disclosed Return on Equity for 5 consecutive years, with 0.01% as the latest value for Q4 2025.
- Quarterly Return on Equity rose 5.0% to 0.01% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.01% through Dec 2025, up 5.0% year-over-year, with the annual reading at 0.01% for FY2025, 5.0% up from the prior year.
- Return on Equity for Q4 2025 was 0.01% at LifeStance Health, up from 0.01% in the prior quarter.
- The five-year high for Return on Equity was 0.01% in Q4 2025, with the low at 0.23% in Q2 2022.
- Average Return on Equity over 5 years is 0.11%, with a median of 0.12% recorded in 2024.
- The sharpest move saw Return on Equity fell -16bps in 2022, then grew 12bps in 2023.
- Over 5 years, Return on Equity stood at 0.2% in 2021, then rose by 29bps to 0.14% in 2022, then increased by 9bps to 0.13% in 2023, then soared by 69bps to 0.04% in 2024, then soared by 119bps to 0.01% in 2025.
- According to Business Quant data, Return on Equity over the past three periods came in at 0.01%, 0.01%, and 0.01% for Q4 2025, Q3 2025, and Q2 2025 respectively.